NAUT Q1 2026 Earnings EPS Beat of 1886 Reflects Cost Discipline Amid PreRevenue Phase Abivax ABVX Q4 2025 Earnings WiderThanExpected Loss Highlights ClinicalStage Costs BORR Q1 2026 Earnings EPS Falls Short of Estimates by a Wide Margin TGL Q3 2024 Earnings Significant EPS Beat Despite Stock Decline SOHON Q2 2025 Earnings Preferred Dividend Coverage Maintained Despite Mixed Lodging Trends RKLB Q1 2026 Earnings EPS Beats Estimates as Rocket Lab Narrows Losses